Statute Details
- Title: Health Products (Medical Devices) Regulations 2010
- Act Code: HPA2007-S436-2010
- Type: Subsidiary legislation (SL)
- Current status (as provided): Current version as at 27 Mar 2026
- Enacting Act (context): Made under the Health Products Act (as indicated by the Act Code and related legislation)
- Commencement: Not specified in the extract (see official commencement in the full text)
- Key subject matter: Regulation of manufacture, import, supply, presentation, advertisement, registration, and post-market obligations for medical devices
- Key provisions (from extract): Section 2 (definitions); Part IA (licensing for manufacturers/importers); Part III (supply and exceptions); Part IV (trade descriptions and labelling); Part V (advertising controls); Part VI (registration and evaluation); Part VIII (duties, record-keeping, reporting, enforcement)
- Notable schedules (from extract): Second Schedule (diseases/conditions for advertising restrictions); Third Schedule (assignment of devices into classes); Fifth Schedule (implantable medical devices)
What Is This Legislation About?
The Health Products (Medical Devices) Regulations 2010 (“MD Regulations”) is Singapore’s core regulatory framework for medical devices. In plain terms, it sets rules for how medical devices may be manufactured, imported, supplied, advertised, and registered—so that devices placed on the market are safe, perform as claimed, and are properly controlled throughout their lifecycle.
The Regulations sit alongside the Health Products Act and related healthcare and biomedical research legislation. They operationalise a risk-based approach: devices are assigned into classes, and the level of regulatory control (licensing, registration, and post-market obligations) increases with risk. The Regulations also create targeted exceptions for activities such as clinical research, charitable purposes, custom-made devices, maintenance/repair, export, and certain phased implementation scenarios.
For practitioners, the MD Regulations are particularly important because they impose not only “front-end” requirements (licensing, registration, labelling, and advertising) but also “back-end” duties (record-keeping, defect/adverse event reporting, recall and field safety corrective action notifications, and compliance with enforcement orders). This means compliance is not a one-off event at the time of registration or importation; it is an ongoing obligation for manufacturers, importers, wholesalers, suppliers, registrants, and—where relevant—qualified practitioners.
What Are the Key Provisions?
1) Definitions and licensing architecture (Part I and Part IA). The Regulations begin with standard preliminary provisions, including definitions (Section 2). The licensing framework is then introduced in Part IA. Sections 2A and 2B set requirements for the issue of a manufacturer’s licence and an importer’s licence respectively. While the extract does not list the detailed criteria, the structure indicates that the Authority’s control is exercised through licensing for key market actors who bring devices into Singapore or produce them for supply.
2) Manufacture and import without a licence (Part II). Part II provides circumstances where manufacture or import may occur without a licence, subject to conditions. Section 3 addresses manufacture of medical devices, with additional provisions for specific contexts: manufacture for clinical research (Section 3A), laboratory-developed tests (Section 3B), charitable purposes for Class A devices (Section 3C), and specified dental medical devices (Section 3D). Import-related provisions include import for personal use (Section 4A), import of devices licensed under the Radiation Protection Act (Section 4B), and import for clinical research (Section 4C).
3) Supply, wholesaling, and exceptions for unregistered devices (Part III). Part III governs supply. Division 1 focuses on wholesale supply, including requirements for a wholesaler’s licence (Section 4D) and rules for wholesaling self-manufactured devices (Section 5) and certain regulated categories (Sections 5A and 5B). Division 2 addresses “unregistered medical devices” and provides exceptions where supply may occur even though registration is not required or not yet completed. Examples include custom-made devices (Section 6), devices after maintenance or repair (Section 7), devices for patients’ use (Section 8), and export or re-export (Section 9). There are also exceptions for non-clinical use (Section 10) and for clinical research (Section 10A), as well as a specific exception for Class A medical devices (Section 10B).
4) Presentation and advertising controls (Parts IV and V). The Regulations regulate how devices are presented to the public and to professionals. Part IV includes provisions on trade descriptions (Section 14), information to be provided with medical devices (Section 15), general labelling requirements (Section 16), and substantiation of claims about uniqueness and prominence (Section 17). Where trade descriptions are contravened, corrective measures may be required (Section 18). Part V then regulates advertising: Section 19 requires that advertisements comply with the medical device advertising regime, while Sections 20 and 21 address substantiation and special rules for “professional use only” devices. Section 22 restricts advertisements promoting medical devices for specified diseases and conditions, and Section 23 empowers the Authority to require copies of advertisements.
5) Registration and evaluation (Part VI). Part VI is central to market access. Section 24 assigns medical devices into classes, and Section 25 sets requirements for registration. Section 26 provides for an evaluation process, and Section 26A introduces a prescribed time for cancellation of registration for non-payment of a retention fee. Section 27 requires disclosure of information on applications for registration. For practitioners, these provisions are critical when advising on regulatory strategy, documentation, and timelines—particularly where registration status affects legality of supply.
6) Post-market duties, reporting, and enforcement (Part VIII). Part VIII imposes ongoing obligations. Section 31 requires licensees, suppliers, and registrants to comply with enforcement orders. Section 32 requires compliance with licence or registration conditions. Sections 33 to 35 set duties of manufacturers, importers, and wholesalers. Section 36 requires registrants to ensure compliance with safety and performance requirements. The Regulations also impose specific duties relating to unregistered Class A devices (Section 35A), sponsors in clinical research contexts (Section 36A), and offences for contravention of duties (Section 37).
Record-keeping and vigilance are heavily emphasised. Section 38 requires maintenance of records of manufacture; Section 39 requires records of supply; Sections 39A and 39B require records relating to receipt, supply, use, and disposal in clinical research contexts. Section 40 requires qualified practitioners to maintain records of implantable medical devices. Section 41 requires records of complaints. Reporting obligations include reporting of defects and adverse effects (Section 42), reporting information adversely affecting quality, safety or efficacy (Section 43), notification to the Authority concerning recall (Section 44), and duties to furnish reports on recall (Section 45) and field safety corrective action (Sections 46 and 47). Finally, Sections 48 and 49 deal with changes affecting licences and changes concerning registered medical devices—important for change control and regulatory notifications.
How Is This Legislation Structured?
The MD Regulations are organised into Parts that track the lifecycle of a medical device:
Part I (Preliminary) contains citation/commencement and definitions (Sections 1 and 2).
Part IA introduces licensing requirements for manufacturers and importers (Sections 2A and 2B).
Part II sets out circumstances for manufacture and import without a licence, with detailed provisions for clinical research, laboratory-developed tests, charitable purposes, dental devices, personal use import, radiation-licensed devices, and clinical research import (Sections 3 to 4C).
Part III governs supply. It includes licensing for wholesale supply (Division 1) and exceptions for unregistered devices (Division 2 and Division 2A), plus requirements for supply of specific categories (Division 3), including Class A devices (Section 12), “professional use only” devices (Section 13), and clinical research/trained user categories (Sections 13A and 13B). It also contains a dedicated emergency medical device exception (Part IIIA, Section 13C).
Parts IV and V regulate presentation and advertising: trade descriptions, labelling and information (Part IV), and advertising rules and restrictions (Part V).
Part VI establishes the registration regime, including classification, registration requirements, evaluation, retention fee cancellation timing, and disclosure duties.
Part VII addresses certificates, including certification for export (Section 30), with some deleted provisions.
Part VIII is the compliance and enforcement backbone, covering duties of market participants, record-keeping, reporting, recall/field safety corrective action notifications, and change management.
Part X (Miscellaneous) includes procedural matters such as notices to the Authority, confidentiality (Section 51A), revocation (Section 52), and savings/transitional provisions (Section 53).
Who Does This Legislation Apply To?
The Regulations apply to a wide range of stakeholders involved in medical devices in Singapore. This includes manufacturers, importers, wholesalers, suppliers, and registrants of medical devices. The licensing and registration provisions mean that entities bringing devices into the market (or supplying them) must ensure they meet the relevant legal requirements for their role.
In addition, the Regulations extend compliance duties to clinical research contexts (including sponsors and related persons), and they impose record-keeping duties on qualified practitioners for implantable medical devices. Reporting obligations and compliance with enforcement orders apply to those who hold licences or registrations, and to those who supply devices under exceptions.
Why Is This Legislation Important?
The MD Regulations are important because they provide the legal basis for controlling medical devices at every stage: pre-market access (licensing and registration), market communication (labelling and advertising), and post-market safety (defect/adverse event reporting, recall and field safety corrective action notifications, and ongoing record-keeping). For legal practitioners, this creates a compliance landscape where liability can arise not only from initial regulatory submissions but also from failures to monitor, document, and report after a device is in use.
From an enforcement perspective, the Regulations’ structure supports both administrative and penal consequences. The explicit “duty to comply with enforcement orders” (Section 31) and the offence provision for contravention of duties (Section 37) indicate that non-compliance can trigger regulatory action and potential criminal liability. Practically, this means counsel should advise clients to implement robust quality management, complaint handling, vigilance systems, and change control processes aligned with the statutory duties.
Finally, the advertising and presentation provisions (Parts IV and V) are significant for commercial and marketing teams. Claims about uniqueness, prominence, and disease/condition targeting are regulated and must be substantiated. This reduces the risk of misleading claims and supports consistent regulatory messaging across the industry.
Related Legislation
- Health Products Act (enabling framework for health product regulation)
- Healthcare Services Act 2020
- Dental Registration Act 1999
- Human Biomedical Research Act 2015
Source Documents
This article provides an overview of the Health Products (Medical Devices) Regulations 2010 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.